HTFL ▼ -1.4% - Heartflow, Inc. $HTFL - Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half HeartFlow shares declined 1.4% despite the company announcing positive late-breaking data from an independent government-funded trial showing its FFRCT analysis reduced unnecessary invasive heart procedures by nearly half. The disconnect between the positive clinical data and the stock's downward movement suggests investors may have had higher expectations for the trial results, or the market may be focusing on other factors such as commercialization timeline, competitive positioning, or broader sector headwinds rather than the efficacy findings themselves. 28-AUG-2026 02:48 AM ET